Possible Role of Metformin as an Immune Modulator in the Tumor Microenvironment of Ovarian Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Possible Role of Metformin as an Immune Modulator in the Tumor Microenvironment of Ovarian Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 2, Pages 867
Publisher
MDPI AG
Online
2021-01-18
DOI
10.3390/ijms22020867
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Neutrophil Metabolic Shift during Their Lifecycle: Impact on Their Survival and Activation
- (2020) Louise Injarabian et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- First-line PARP inhibition in ovarian cancer — standard of care for all?
- (2020) Susana N. Banerjee et al. Nature Reviews Clinical Oncology
- Activated CAMKKβ-AMPK signaling promotes autophagy in a spheroid model of ovarian tumour metastasis
- (2020) Jeremi Laski et al. Journal of Ovarian Research
- Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer
- (2020) Yufei Wang et al. Cells
- Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer
- (2020) Jason R Brown et al. JCI Insight
- CD4 + T-Cell Endogenous Cystathionine γ Lyase-Hydrogen Sulfide Attenuates Hypertension by Sulfhydrating Liver Kinase B1 to Promote T Regulatory Cell Differentiation and Proliferation
- (2020) Changting Cui et al. CIRCULATION
- High-throughput approaches for precision medicine in high-grade serous ovarian cancer
- (2020) Meinusha Govindarajan et al. Journal of Hematology & Oncology
- C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights
- (2020) Peter C. Hart et al. Frontiers in Immunology
- Association of metformin use with ovarian cancer incidence and prognosis: a systematic review and meta-analysis
- (2019) Jinghua Shi et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- SPHK1 is a novel target of metformin in ovarian cancer
- (2019) Peter C Hart et al. MOLECULAR CANCER RESEARCH
- Comprehensive Phenotyping of T Cells Using Flow Cytometry
- (2019) Charlotte M. Mousset et al. CYTOMETRY PART A
- Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus
- (2019) Tuba T Duman et al. African Health Sciences
- AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging
- (2019) Antero Salminen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview
- (2019) Huiyan Cheng et al. Frontiers in Oncology
- Proteome Analysis Reveals Distinct Mitochondrial Functions Linked to Interferon Response Patterns in Activated CD4+ and CD8+ T Cells
- (2019) Marlene C. Gerner et al. Frontiers in Pharmacology
- Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer
- (2019) Thaïs Baert et al. Frontiers in Immunology
- Monocarboxylate transporters in cancer
- (2019) Valéry L. Payen et al. Molecular Metabolism
- Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors
- (2019) An Coosemans et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic significance of neutrophil–lymphocyte ratio (NLR) in patients with ovarian cancer
- (2019) Xinming Yin et al. MEDICINE
- Chronic inflammation in the etiology of disease across the life span
- (2019) David Furman et al. NATURE MEDICINE
- Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk
- (2019) Peter C. Hart et al. Cell Reports
- The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo
- (2018) Lisa Menegazzo et al. ACTA DIABETOLOGICA
- Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
- (2018) Lifeng Li et al. CANCER RESEARCH
- Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer
- (2018) Sen Xu et al. MOLECULAR CANCER THERAPEUTICS
- A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy‐Naïve Advanced or Metastatic Nonsquamous Non‐Small Cell Lung Cancer
- (2018) Kristen A. Marrone et al. ONCOLOGIST
- PARP Inhibitors in Epithelial Ovarian Cancer
- (2018) Kristin N. Taylor et al. Recent Patents on Anti-Cancer Drug Discovery
- Insulin Receptor-Mediated Stimulation Boosts T Cell Immunity during Inflammation and Infection
- (2018) Sue Tsai et al. Cell Metabolism
- LKB1 deficiency in T cells promotes the development of gastrointestinal polyposis
- (2018) M. C. Poffenberger et al. SCIENCE
- Prediction of DNA Repair Inhibitor Response in Short Term Patient-Derived Ovarian Cancer Organoids
- (2018) Sarah J. Hill et al. Cancer Discovery
- Regulation of T cell immunity by cellular metabolism
- (2018) Zhilin Hu et al. Frontiers of Medicine
- The journey of metformin from glycaemic control to mTOR inhibition and the suppression of tumour growth
- (2018) Sam Amin et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
- (2018) Bagher Farhood et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
- (2018) WonJae Lee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876
- (2018) Yibao Ma et al. Cancers
- The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
- (2017) Bertrand Allard et al. IMMUNOLOGICAL REVIEWS
- Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity
- (2017) Takahiro Horiuchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The histophysiology and pathophysiology of the peritoneum
- (2017) J.O.A.M van Baal et al. TISSUE & CELL
- Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo
- (2017) Stephan Halle et al. TRENDS IN IMMUNOLOGY
- High grade serous ovarian carcinomas originate in the fallopian tube
- (2017) S. Intidhar Labidi-Galy et al. Nature Communications
- Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling
- (2017) Chi-Fu Chiang et al. Oncotarget
- Metformin induces distinct bioenergetic and metabolic profiles in sensitive versus resistant high grade serous ovarian cancer and normal fallopian tube secretory epithelial cells
- (2017) Melissa Hodeib et al. Oncotarget
- The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer
- (2017) Jun Li et al. Oncotarget
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- Attenuation of CD4 + CD25 + Regulatory T Cells in the Tumor Microenvironment by Metformin, a Type 2 Diabetes Drug
- (2017) Yuki Kunisada et al. EBioMedicine
- Changes in CD73, CD39 and CD26 expression on T-lymphocytes of ANCA-associated vasculitis patients suggest impairment in adenosine generation and turn-over
- (2017) Lovis Kling et al. Scientific Reports
- Are Metformin Doses Used in Murine Cancer Models Clinically Relevant?
- (2016) Navdeep S. Chandel et al. Cell Metabolism
- AMPK Is Essential to Balance Glycolysis and Mitochondrial Metabolism to Control T-ALL Cell Stress and Survival
- (2016) Rigel J. Kishton et al. Cell Metabolism
- Metformin Scavenges Methylglyoxal To Form a Novel Imidazolinone Metabolite in Humans
- (2016) Owen R. Kinsky et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Anti-Inflammatory Effects of Metformin Irrespective of Diabetes StatusNovelty and Significance
- (2016) Amy R. Cameron et al. CIRCULATION RESEARCH
- Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells
- (2016) Naoki Horikawa et al. CLINICAL CANCER RESEARCH
- Preclinical evaluation of olaparib and metformin combination in BRCA1 wildtype ovarian cancer
- (2016) M. Hijaz et al. GYNECOLOGIC ONCOLOGY
- Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial
- (2016) Takuma Higurashi et al. LANCET ONCOLOGY
- Milky spots: omental functional units and hotbeds for peritoneal cancer metastasis
- (2016) Jiuyang Liu et al. TUMOR BIOLOGY
- Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator
- (2016) Prashant Trikha et al. OncoImmunology
- Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models
- (2015) Ernst Lengyel et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- The development of PARP inhibitors in ovarian cancer: from bench to bedside
- (2015) Yvette Drew BRITISH JOURNAL OF CANCER
- Metformin: a modulator of bevacizumab activity in cancer? A case report
- (2015) Stefano Indraccolo et al. CANCER BIOLOGY & THERAPY
- Immune-mediated antitumor effect by type 2 diabetes drug, metformin
- (2015) Shingo Eikawa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Contribution of metabolic reprogramming to macrophage plasticity and function
- (2015) Karim C. EL Kasmi et al. SEMINARS IN IMMUNOLOGY
- MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer
- (2015) Peter C. Hart et al. Nature Communications
- Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer
- (2015) Lacey M. Litchfield et al. Oncotarget
- Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
- (2015) Bin Shang et al. Scientific Reports
- Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions
- (2015) Clovis S. Palmer et al. Frontiers in Immunology
- Metformin limits the adipocyte tumor-promoting effect on ovarian cancer
- (2015) Calvin Tebbe et al. Oncotarget
- Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
- (2014) Kıvanç Birsoy et al. NATURE
- A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
- (2014) Meiying Zhang et al. Journal of Ovarian Research
- Interaction of monocytes/macrophages with ovarian cancer cells promotes angiogenesisin vitro
- (2013) Xipeng Wang et al. CANCER SCIENCE
- HMGB1: The Central Cytokine for All Lymphoid Cells
- (2013) Guanqiao Li et al. Frontiers in Immunology
- Metformin intake is associated with better survival in ovarian cancer
- (2012) Sanjeev Kumar et al. CANCER
- AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo
- (2012) Brandon Faubert et al. Cell Metabolism
- Distinct metabolic programs in activated T cells: opportunities for selective immunomodulation
- (2012) Daniel R. Wahl et al. IMMUNOLOGICAL REVIEWS
- Metformin inhibits the development and metastasis of ovarian cancer
- (2012) BUCHU WU et al. ONCOLOGY REPORTS
- Hypoxia-inducible factor 1 transcriptional activity in endothelial cells is required for acute phase cardioprotection induced by ischemic preconditioning
- (2012) K. Sarkar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- The Liver Kinase B1 Is a Central Regulator of T Cell Development, Activation, and Metabolism
- (2011) Nancie J. MacIver et al. JOURNAL OF IMMUNOLOGY
- Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity
- (2011) Iris L. Romero et al. OBSTETRICS AND GYNECOLOGY
- Cancer-related inflammation: Common themes and therapeutic opportunities
- (2011) Frances R. Balkwill et al. SEMINARS IN CANCER BIOLOGY
- PARP inhibitors: its role in treatment of cancer
- (2011) Alice Chen Chinese Journal of Cancer
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- CD73 on Tumor Cells Impairs Antitumor T-Cell Responses: A Novel Mechanism of Tumor-Induced Immune Suppression
- (2010) D. Jin et al. CANCER RESEARCH
- Neutrophils: key mediators of tumour angiogenesis
- (2010) Simon Tazzyman et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Alterations of histone modifications by cobalt compounds
- (2009) Qin Li et al. CARCINOGENESIS
- LKB1 is essential for the proliferation of T-cell progenitors and mature peripheral T cells
- (2009) Peter Tamás et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
- (2007) William E. Winter et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now